Autism Spectrum Disorder Trial, Recruiting NCT07134569 Sponsor: National Taiwan University Hospital Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT07134569
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

ASD Group

Who might be able to join this trial:

  • Adults aged between 18 and 45 years who have a formal diagnosis of Autism Spectrum Disorder (ASD) made by a licensed mental health or medical professional, based on standard diagnostic guidelines (DSM-5)
  • People who are willing and motivated to complete a 6-week motor (movement and physical function) training program using virtual reality (VR)
  • People who have scored above 70 on a standard intelligence assessment called the WAIS-IV (confirm with trial site)

Who may not be able to join:

  • People with a history of major mental illness (such as bipolar disorder, schizophrenia, or psychosis), neurological conditions that affect walking ability (such as stroke, back nerve problems, or spinal cord injury), or who have had brain or spinal surgery
  • People with vision or hearing difficulties that would prevent them from taking part in the movement assessments or training activities

Non-ASD Control Group

Who might be able to join this trial:

  • Adults aged between 18 and 45 years who do not have a diagnosis of ASD
  • People who have scored above 70 on a standard intelligence assessment called the WAIS-IV (confirm with trial site)

Who may not be able to join:

  • People with a history of major mental illness (such as bipolar disorder, schizophrenia, or psychosis), neurological conditions or brain or spinal surgery that affects walking ability (such as stroke, back nerve problems, or spinal cord injury)
  • People with vision or hearing difficulties that would prevent them from taking part in the movement assessments or training activities

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +886 2-23123456

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 December 2023
Est. completion
31 July 2027

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

The performance of movement operational assessment; The performance of motor coordination control

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov